Halozyme Therapeutics, Inc. (HALO)
71.21
-0.61
(-0.85%)
USD |
NASDAQ |
Jan 16, 16:00
70.44
-0.77
(-1.08%)
After-Hours: 07:54
Halozyme Therapeutics Market Cap: 8.374B for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 526.82B |
| Merck & Co., Inc. | 270.12B |
| AIM ImmunoTech, Inc. | 3.942M |
| Stryker Corp. | 139.12B |
| Skye Bioscience, Inc. | 32.06M |
Market Cap Related Metrics
| PE Ratio | 14.97 |
| PS Ratio | 7.192 |
| PEG Ratio | 0.2607 |
| Price to Book Value | 16.62 |
| Price to Free Cash Flow | 14.84 |
| Price | 71.21 |
| Earnings Yield | 6.68% |
| PEGY Ratio | 0.2607 |
| Operating PE Ratio | 12.12 |
| Normalized PE Ratio | 14.97 |